MAP2K7 and Langerhans cell histiocytosis: Treatment of LCH is variable with some patients requiring no treatment and others requiring steroids, chemotherapy (standard treatment for MS LCH is combination prednisolone and vinblastine), surgery (curettage), rarely bone marrow transplantation (85), or increasingly, targeted therapy, namely BRAF +/- MEK inhibitors.